Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Aug 2017 08:33

RNS Number : 8580M
Immunodiagnostic Systems Hldgs PLC
02 August 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Immunodiagnostic Systems Holdings Plc

10 Didcot Way, Boldon Business Park, Tyne & Wear NE35 9PD, UK

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Exemption to the aggregation of holdings provided under DTR 5.4.1R of the FCA Handbook.

X

3. Details of person subject to the notification obligationiv

Name

BNY Mellon Service Kapitalanlage-Gesellschaft mbH

City and country of registered office (if applicable)

Frankfurt, Germany

4. Full name of shareholder(s) (if different from 3.)v

Name

N/A

City and country of registered office (if applicable)

N/A

5. Date on which the threshold was crossed or reachedvi:

31 July 2017

6. Date on which issuer notified (DD/MM/YYYY):

1 August 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.50%

N/A

9.50%

29,413,543

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Common Stock

GB00B01YZ052

2,795,252

N/A

9.50%

N/A

SUBTOTAL 8. A

2,795,252

9.50%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8. B 1

N/A

N/A

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8.B.2

N/A

N/A

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

N/A

N/A

N/A

N/A

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

N/A

 

Place of completion

Uniondale, New York

Date of completion

1 August 2017

 

 

 

Notes

 

i Please note that national forms may vary due to specific national legislation (Article 3(1a) of Directive 2004/109/EC) as for instance the applicable thresholds or information regarding capital holdings.

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h)/ Article 10 (b) to (h) of Directive 2004/109/EC; (c) all parties to the agreement referred to in Article 10 (a) of Directive 2004/109/EC (DTR5.2.1 (a)) or (d) the holder of financial instruments referred to in Article 13(1) of Directive 2004/109/EC (DTR5.3.1).

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in points (b) to (h) of Article 10 of Directive 2004/109/EC (DTR5.2.1 (b) to (h)), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 10 of that Directive (DTR5.2.1 (b)), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 10 of that Directive (DTR5.2.1 (c)), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 10 of that Directive (DTR5.2.1 (d)), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 10 of that Directive (DTR5.2.1 (e)), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9 (DTR 5.1), under letters (a) to (d) of Article 10 of that Directive (DTR5.2.1 (a) to (d)) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 10 of that Directive (DTR5.2.1 (f)), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 10 of that Directive (DTR5.2.1 (g)), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 10 of that Directive (DTR5.2.1 (h)), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC (DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 10 of that Directive (DTR5.2) unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold in accordance with national law, please note that it might not be necessary in accordance with national law to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (Article 13(1a) of Directive 2004/109/EC) (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only thus the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain leaving a row free between different chains (e.g.: A, B, C, free row, A, B, D, free row, A, E, F etc.).

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUOBRBUAWRRR
Date   Source Headline
13th Jul 20217:00 amRNSCancellation - Immunodiagnostic Systems Hldgs PLC
12th Jul 202111:54 amRNSScheme of Arrangement becomes Effective
12th Jul 20217:30 amRNSSuspension- Immunodiagnostic Systems Holdings PLC
9th Jul 202110:47 amRNSForm 8 (DD) - Immunodiagnostic Systems Hldgs PLC
9th Jul 202110:47 amRNSForm 8 (DD) - Immunodiagnostic Systems Hldgs PLC
8th Jul 20213:13 pmRNSExercise of Options
8th Jul 202111:52 amRNSCourt Sanction of the Scheme of Arrangement
5th Jul 20215:30 pmRNSImmunodiagnostic Systems Hldgs
1st Jul 202111:53 amRNSResults of Court Meeting and General Meeting
22nd Jun 202112:40 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
22nd Jun 20219:22 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Hldgs
22nd Jun 20217:00 amRNSForm 8.3 - Immunodiagnostic
11th Jun 20212:40 pmRNSForm 8.3 - [Immunodiacnostic Systems]
11th Jun 202112:00 pmRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Hldgs
10th Jun 20212:00 pmEQSAmendment of Form 8.3 - Shareholder Value Beteiligungen AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
10th Jun 202111:31 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
9th Jun 202112:12 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings plc
4th Jun 20219:23 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
4th Jun 20218:23 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
3rd Jun 20215:43 pmRNSPublication of Scheme Document
3rd Jun 20217:00 amRNSAdditional Listing to Correct Discrepancy
28th May 20214:13 pmEQSForm 8.3 Immunodiagnostic Systems Holdings PLC
28th May 20213:58 pmEQSForm 8.3 - Shareholder Value Beteiligungen AG: Immunodiagostic Systems Holdings PLC
28th May 20219:33 amEQSForm 8 - Shareholder Value Beteiligungen AG: 8.3 Immunodiagnostic Holding PLC
28th May 20219:26 amEQSShareholder Value Management AG: Form 8.3 Immunodiagnostic Systems Holdings PLC
27th May 20218:57 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
26th May 20219:10 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
25th May 20214:14 pmRNSForm 8.3 - Immunodiagnostic Systems Hldgs PLC
25th May 202110:00 amRNSForm 8.3 - [IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC]
25th May 20218:20 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
24th May 20211:39 pmRNSForm 8 (OPD) - Immunodiagnostic Systems Hldgs PLC
24th May 202110:58 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
21st May 20219:41 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
21st May 20218:37 amRNSForm 8.3 - Immunodiagnostic Systems Hldgs PLC
20th May 202110:49 amRNSForm 8.3 - Immunodiagnostic Systems Holding PLC
20th May 202110:23 amRNSForm 8.3 - [Immunodiagnostic Systems Holding PLC]
20th May 20219:55 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
19th May 20219:58 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
19th May 20219:32 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20215:03 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20212:33 pmRNSDirector/PDMR Shareholding
18th May 20212:16 pmPRNForm 8.3 - Immunodiagnostic Systems Holdings Plc
18th May 202112:16 pmRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
18th May 20219:16 amRNSForm 8.5 (EPT/RI) - Immunodiagnostic Systems Plc
18th May 20218:50 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
17th May 20219:05 amRNSSecond Price Monitoring Extn
17th May 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.